Epidemiology of chronic daily headache
- 146 Downloads
Daily or near-daily headache is a widespread problem in clinical practice. The general term of chronic daily headache (CDH) encompasses those primary headaches presenting more than 15 days per month and lasting more than 4 hours per day. CDH includes transformed migraine (TM), chronic tension-type headache (CTTH), new daily persistent headache (NDPH), and hemicrania continua (HC). Around 40% of patients attending a specialized headache clinic meet CDH diagnostic criteria, of which 80% are women. In these clinics about 60% of patients suffer from TM, 20% from CTTH, and 20% meet NDPH criteria. Most, some 80%, overuse symptomatic medications. One should be very cautious on extrapolating these numbers to the general population. CDH prevalence in the general population seems to be around 4% to 5% (up to 8% to 9% for women). Regarding the prevalence of CDH subtypes, NDPH is rare (0.1%), whereas the prevalence of TM (1.5% to 2%) and CTTH (2.5% to 3%) is clearly higher. In contrast to data from specialized clinics, only around a quarter of CDH subjects in the general population overuse analgesics; the prevalence of CDH subjects with analgesic overuse being 1.1% to 1.9% of the general population. Most of these patients with analgesic overuse are TM patients.
KeywordsMigraine Chronic Daily Headache International Headache Society Medication Overuse Paroxysmal Hemicrania
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society [no authors listed]. Cephalalgia 1988, 8(suppl 7):1-96.Google Scholar
- 5.Sanin LC, Mathew NT, Bellmyer LR, Ali S: The International Headache Society (IHS) headache classification as applied to a headache clinic population. Headache 1994, 14:443–446.Google Scholar
- 12.Silberstein SD, Lipton RB: Chronic daily headache. In Headache. Edited by Goadsby P, Silberstein SD. Boston: Butterworth-Heinemann; 1997:733–741.Google Scholar
- 15.Castillo J, Muñoz P, Guitera V, Pascual J: Epidemiology of chronic daily headache in the general population. Headache 1999, 39:190–196. A large survey with in-person clinical assessments studying the prevalence of CDH and CDH subtypes following Silberstein et al.’s [2,13] criteria.PubMedCrossRefGoogle Scholar
- 16.Guitera V, Muñoz P, Castillo J, Pascual J: Transformed migraine: a proposal for the modification of its diagnostic criteria based on recent epidemiological data. Cephalalgia 1999, 19:847–850. Proposal for new diagnostic criteria for TM based on the experience of the authors after 1 year of follow-up of CDH patients in a general population sample.PubMedCrossRefGoogle Scholar
- 21.Hagen K, Zwart JA, Vatten L, et al.: Prevalence of migraine and non-migrainous headache-head-HUNT, a large populationbased study. Cephalalgia 2000, 20:900–906. Large (51,383 subjects) epidemiologic study in Norway to estimate the 1-year prevalence of migraine, nonmigrainous headache, frequent headache (> 6 d/mo), and CDH. CDH prevalence was 2%, the lowest for all epidemiologic studies.PubMedCrossRefGoogle Scholar
- 23.Prencipe M, Casini AR, Ferretti C, et al.: Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry 2001, 70:377–381. Door-to-door prevalence study in more than 800 elderly subjects in central Italy.PubMedCrossRefGoogle Scholar
- 26.Diener HC, Tfelt-Hansen P: Headache associated with chronic use of substances. In The Headaches. Edited by Olesen J et al. New York: Raven Press; 1993:721–727.Google Scholar